Molina Healthcare (MOH) Projected to Post Quarterly Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is expected to be issuing its Q2 2025 quarterly earnings data after the market closes on Wednesday, July 23rd. Analysts expect the company to announce earnings of $6.12 per share and revenue of $10.94 billion for the quarter. Molina Healthcare has set its FY 2025 guidance at 24.500- EPS.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.96 by $0.12. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The firm had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same quarter last year, the business earned $5.73 earnings per share. Molina Healthcare’s revenue was up 12.2% compared to the same quarter last year. On average, analysts expect Molina Healthcare to post $24 EPS for the current fiscal year and $28 EPS for the next fiscal year.

Molina Healthcare Stock Down 2.1%

Shares of NYSE MOH opened at $214.35 on Wednesday. Molina Healthcare has a 1 year low of $213.22 and a 1 year high of $365.23. The firm’s 50 day moving average price is $289.21 and its 200 day moving average price is $302.23. The firm has a market cap of $11.62 billion, a P/E ratio of 10.35, a price-to-earnings-growth ratio of 0.92 and a beta of 0.55. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.63 and a current ratio of 1.63.

Analyst Ratings Changes

MOH has been the topic of a number of research analyst reports. Barclays decreased their price target on shares of Molina Healthcare from $351.00 to $347.00 and set an “equal weight” rating on the stock in a report on Monday, June 9th. Sanford C. Bernstein initiated coverage on shares of Molina Healthcare in a report on Tuesday, April 22nd. They issued an “outperform” rating and a $414.00 price target on the stock. Mizuho set a $330.00 price target on shares of Molina Healthcare and gave the company an “outperform” rating in a report on Friday, July 11th. Baird R W lowered shares of Molina Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Finally, Guggenheim initiated coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating on the stock. Eleven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $352.21.

Insiders Place Their Bets

In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the transaction, the chief executive officer owned 257,715 shares of the company’s stock, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the sale, the director directly owned 11,244 shares in the company, valued at $3,603,702. This trade represents a 5.62% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.26% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Baird Financial Group Inc. acquired a new stake in shares of Molina Healthcare in the 1st quarter valued at about $210,000. NewEdge Advisors LLC raised its stake in shares of Molina Healthcare by 33.4% in the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock valued at $364,000 after purchasing an additional 277 shares in the last quarter. Jones Financial Companies Lllp raised its stake in shares of Molina Healthcare by 713.3% in the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock valued at $544,000 after purchasing an additional 1,448 shares in the last quarter. Focus Partners Wealth raised its stake in shares of Molina Healthcare by 82.7% in the 1st quarter. Focus Partners Wealth now owns 3,749 shares of the company’s stock valued at $1,235,000 after purchasing an additional 1,697 shares in the last quarter. Finally, Woodline Partners LP acquired a new stake in shares of Molina Healthcare in the 1st quarter valued at about $1,541,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.